Active ingredients
Pharmacological Group
Used in the treatment
- T14.1 Open wound of unspecified body region
- N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere
- N76 Other inflammation of vagina and vulva
- N74.4 Female Chlamydial pelvic inflammatory disease (A56.1+)
- L98.9 Disorder of skin and subcutaneous tissue, unspecified
- L98.4.2* Trophic skin ulcer
- L89 Decubitus ulcer and pressure area
- L30.3 Infective dermatitis
- L00-L08 Infections of the skin and subcutaneous tissue
- J03.9 Acute tonsillitis, unspecified
- J02.9 Acute pharyngitis, unspecified
- B00 Herpesviral [Herpes simplex] infections
- T79.3 Post-traumatic wound infection, not elsewhere classified
- Z01.2 Dental examination
- Z40 Prophylactic surgery
- Z41.8 Other procedures for purposes other than remedying health state
- Z100* CHAPTER XXII Surgical practice
- O06 Unspecified abortion
- N84 Polyp of female genital tract
- L87 Transepidermal elimination disorders
- B35-B49 Mycoses
- Z30.1 Insertion of (intrauterine) contraceptive device
- Z34 Supervision of normal pregnancy
- Y83.9 Abnormal reaction/later complication, without mention of misadventure at the time of the procedure, surgical procedure, unspecified